• 제목/요약/키워드: aroE

검색결과 24건 처리시간 0.033초

$aroP^{-}$변이가 E.coli에서 트립토판 방출에 미치는 영향 (Effects of $aroP^{-}$ mutation on the tryptophan excretion in escherichia coli)

  • 지연태;안병우;이세영
    • 미생물학회지
    • /
    • 제23권1호
    • /
    • pp.9-12
    • /
    • 1985
  • 증폭된 재조합 trp operon의 발현을 위한 숙주박테리아 개발의 일환으로 숙수 E. coli에 $aroP^{-}$ 변이를 도입하였다. $aroP^{-}$ 변이의 유도에는 trans po son Tn10을 사용하였으며 P1Kc파아지를 이용하여 숙주박테리아에 형질도입하였다. General aromatic amino acid transport system이 결여된 $aroP^{-}$ 변이주는 $\beta$-thienylalanine ($(2{\times}10^{-4}M)$). p-fluor-phenylalanine ($(2{\times}10^{-4}M)$) 그리고 5-methyltryptophan에 저항성을 가졌다. $aroP^{-}$ 변이주는 $aroP^{-}$ 야생주에 비해서 〔$[^3H]$-tryptophan uptake가 상당히 감소하였다. 또한 NaN, ($(2{\times}10^{-4}M)$)를 처리하였을 때의 ($[^3H]$)-tryptophan uptake 비율은 aroP 변이주가 $aroP^{-}$야생주보다 덜 감소하였다. E. coli $trpR^{-ts}/ColE_1 -trp^+$ 균주에 aroP 형질을 도입하였을 때 트립토판 방출이 $aroP^{-}$ 야생주에 비해서 4 배나 증가하였다.

  • PDF

Salmonella typhi KNIH100으로부터 aroA 유전자의 클로닝과 염기서열 분석 (Cloning and Nucleotide Sequence Analysis of the aroA Gene from Salmonella typhi KNIH100)

  • 길영식;신희정;김영창
    • 미생물학회지
    • /
    • 제36권1호
    • /
    • pp.46-51
    • /
    • 2000
  • 장티푸스는 Salmonella typhi에 의해 유발되는 장감염성 질환으로 사람과 동물에 공통되는 질병이다. 본 연구에서는 국립보건원과 공동연구를 수행하여 한국형 장티푸스 유발균인 S. typhi KNIH100을 분리하였다. 분리된 S. typhi KNIH100의 염색체 DNA로부터 방향족 아미노산의 생합성에 관여하는 효소인 5-enolpyruvylshikimate-3-phosphate synthetase를 암호화하는 aroA 유전자를 포함하는 약 5.0 kb의 SalI절편을 pBluescriptII SK(+) vector와 aroA 돌연변이주인 E. coli CGSC2829를 이용하여 클로닝하였다. 그리고 이 클론을 pSAL80이라 명명하였다. 클로닝된 재조합 plasmid인 pSAL80에는 ATG 개시코돈과 TGA 종결코돈을 포함하는 1,284 염기로 구성된 aroA 유전자가 위치하고 있었으며, 다른 장내세균과 마찬가지로 serC와 하나의 오페론을 구성하고 있음을 밝혔다. 또한 S. typhi Ty2, S. typhimurium, 그리고 E. coli 등 다른 장내세균의 aroA 유전자와 상동성을 비교하여 본 결과 각각 99%, 95%, 77%의 상동성을 나타내었다.

  • PDF

Effects of tktA, $aroF^{FBR}$and aroL Expression in the Tryptophan-Producing Escherichia coli

  • Kim, Tae-Hyun;Namgoong, Suk;Kwak, Joon-Hyeok;Lee, Se-Yong;Lee, Heung-Shick
    • Journal of Microbiology and Biotechnology
    • /
    • 제10권6호
    • /
    • pp.789-796
    • /
    • 2000
  • In order to analyze the effects of tktA, $aroF^{FBR}$, and aroL expression in a tryptophan-producing Escherichia coli, a series of plasmids carrying the genes were constructed. Introduction of tktA, $aroF^{FBR}$, and aroL into the E. coli strain resulted in approximately 10-20 fold increase in the activities of transketolase, the feedback inhibition-resistant 3-deoxy-D-arabinoheptulsonate-7-phosphate synthase, and shikimate kinase. Expression of $aroF^{FBR}$ in the aroB mutant strain of E. coli resulted in the accumulation of 10 mM of 3-deoxy-D-arabinoheptulsonate-7-phosphate (DAHP) in the medium. Simultaneous expression of tktA and $aroF^{FBR}$ in the strain further increased the amount of excreted DAHP to 20 mM. In contrast, the mutant strain which has no gene introduced accumulated 0.5 mM of DAHP. However, the expression of tktA and $aroF^{FBR}$ in a tryptophan-producing E. coli strain did not lead to the increased production of tryptophan, but instead, a significant amount of shikimate, which is an intermediate in the tryptophan biosynthetic pathway, was excreted to the growth medium. Despite the fact that additional expression of shikimate kinase in the strain could possibly remove 90% of excreted shikimate to 0.1 mM, the amount of tryptophan produced was still unchanged. Removing shikimate using a cloned aroL gene caused the excretion of glutamate, which suggests disturbed central carbon metabolism. However, when cultivated in a complex medium, the strain expressing tktA, $aroF^{FBR}$, and aroL produced more tryptophan than the parental strain. These data indicate that additional rate-limiting steps are present in the tryptophan biosynthetic pathway, and the carbon flow to the terminal pathway is strictly regulated. Expressing tktA in E. coli cells appeared to impose a great metabolic burden to the cells as evidenced by retarded cell growth in the defined medium. Recombinant E. coli strains harboring plasmids which carry the tktA gene showed a tendency to segregate their plasmids almost completely within 24h.

  • PDF

Salmonella typhi KNIH100으로부터 aroD 유전자의 클로닝과 염기서열 분석 (Cloning and Nucleotide Sequence Analysis of the aroD Gene from Salmonella typhi KNIHI100)

  • 길영식;전형규;신희정;김영창
    • 미생물학회지
    • /
    • 제36권3호
    • /
    • pp.187-191
    • /
    • 2000
  • 장티푸스는 Salmonella typhi 에 의해 유발되는 장감염성 질환으로 사람과 동물에 공통되는 질병이다. 본 연구에서는 기 보고된Salmonella typhi KNH100의 염색체 DNA로부 터 방향족 아미노산의 생합성에 관여하는 효소인 3-dehydroquinate hydratase(3- dehydroquinate)를 암호화하는 aroD 유전자를 포함하는 약 3.2 kb의 Sal I 절편을 pSAL62 이라 명명하였다. 클로닝된 재조합 plasmid인 pSAL61에는 ATG 개시코돈과 TGA 종결코돈 을 포함하는 759 염기로 구성된 aroD 유전자가 위치하고 있었다. 또한 S. typhi Ty2, Shigella dysenteriae, 그리고 Escherichia coli 등 다른 장내 세균의 aroD 유전자와 상동성을 비교하여 본 결과 각각 90%, 72.7% 그리고 73%의 상동성을 나타내었다.

  • PDF

Transcriptional Regulation of Escherichia coli serC-aroA Operon : Further Support for cAMP-Dependent Expression

  • Sa, Jae-Hoon;Park, Soo-Sun;Lim, Chang-Jin
    • BMB Reports
    • /
    • 제28권1호
    • /
    • pp.21-26
    • /
    • 1995
  • The Escherichia coli mixed-function serC-aroA operon encodes biosynthethic enzymes for unrelated pathways leading to the syntheses of serine and aromatic amino acids. It has been proposed that the operon is expressed in a cAMP-dependent manner. In this work experiments were performed to investigate the cAMP-dependent expression of the operon. Exogenous cAMP increased ${\beta}$-galactosidase synthesis in the $cya^+$ and cya strains harboring the serC-aroA-lac fusion plasmid. This enhancement was more dramatic in the $cya^-$ strain grown in a minimal medium. In a dot blot assay the serC-aroA mRNA content increased in a concentration-dependent pattern after the addition of exogenous cAMP. The activity of phosphoserine aminotransferase, encoded by the serC gene, apparently increased in E. coli cells after the addition of cAMP. All results obtained confirmed that the expression of the E. coli serC-aroA operon is positively regulated by cAMP at the level of transcription.

  • PDF

방향족 아미노산에 의한 대장균 serC-aroA Operon의 발현 억제 (Repression of Escherichia coli serC-aroA Operon by Aromatic Amino Acids)

  • 황우길;사재훈;김경훈;임창진
    • 미생물학회지
    • /
    • 제32권2호
    • /
    • pp.109-114
    • /
    • 1994
  • 대장균에서 두 가지 다른 아미노산의 생합성에 관여하는 serC 유전자와 araA유전자는 혼합 operon을 이루고 있다. SerC-aroA 혼합 operon의 발현 조절 현상을 serC-aroA-lacZ fusion plasmid pWH2를 이용하여 측정하였다. serC-aroA 혼합 operon의 발현은 L-tyrosine, L=phenulalanine 및 L-tryptophan 등 방향족 아미노산들에 의하여 억제되었다. 방향족 아미노산에 의한 억제 효과는 $tyrR^-$ 균주 혹은 $trpT^-$ 균주에서는 감소하였다. 또한, 방향족 아미노산은 cyclic AMP에 의한 이 operon의 발현 상승 효과를 감소시키기도 하였다. 이들 결과로부터 대장균 serC-aroA 혼합 operon의 발현은 방향종 아미노산들에 의해 억제된다고 추정하였다.

  • PDF

CRISPR-Driven Genome Engineering for Chorismate- and Anthranilate-Accumulating Corynebacterium Cell Factories

  • Hye-Jin Kim;Si-Sun Choi;Eung-Soo Kim
    • Journal of Microbiology and Biotechnology
    • /
    • 제33권10호
    • /
    • pp.1370-1375
    • /
    • 2023
  • In this study, we aimed to enhance the accumulation of chorismate (CHR) and anthranilate (ANT), key intermediates in the shikimate pathway, by modifying a shikimate over-producing recombinant strain of Corynebacterium glutamicum [19]. To achieve this, we utilized a CRISPR-driven genome engineering approach to compensate for the deletion of shikimate kinase (AroK) as well as ANT synthases (TrpEG) and ANT phosphoribosyltransferase (TrpD). In addition, we inhibited the CHR metabolic pathway to induce CHR accumulation. Further, to optimize the shikimate pathway, we overexpressed feedback inhibition-resistant Escherichia coli AroG and AroH genes, as well as C. glutamicum AroF and AroB genes. We also overexpressed QsuC and substituted shikimate dehydrogenase (AroE). In parallel, we optimized the carbon metabolism pathway by deleting the gntR family transcriptional regulator (IolR) and overexpressing polyphosphate/ATP-dependent glucokinase (PpgK) and glucose kinase (Glk). Moreover, acetate kinase (Ack) and phosphotransacetylase (Pta) were eliminated. Through our CRISPR-driven genome re-design approach, we successfully generated C. glutamicum cell factories capable of producing up to 0.48 g/l and 0.9 g/l of CHR and ANT in 1.3 ml miniature culture systems, respectively. These findings highlight the efficacy of our rational cell factory design strategy in C. glutamicum, which provides a robust platform technology for developing high-producing strains that synthesize valuable aromatic compounds, particularly those derived from the shikimate pathway metabolites.

Shikimate Metabolic Pathway Engineering in Corynebacterium glutamicum

  • Park, Eunhwi;Kim, Hye-Jin;Seo, Seung-Yeul;Lee, Han-Na;Choi, Si-Sun;Lee, Sang Joung;Kim, Eung-Soo
    • Journal of Microbiology and Biotechnology
    • /
    • 제31권9호
    • /
    • pp.1305-1310
    • /
    • 2021
  • Shikimate is a key high-demand metabolite for synthesizing valuable antiviral drugs, such as the anti-influenza drug, oseltamivir (Tamiflu). Microbial-based strategies for shikimate production have been developed to overcome the unstable and expensive supply of shikimate derived from traditional plant extraction processes. In this study, a microbial cell factory using Corynebacterium glutamicum was designed to overproduce shikimate in a fed-batch culture system. First, the shikimate kinase gene (aroK) responsible for converting shikimate to the next step was disrupted to facilitate the accumulation of shikimate. Several genes encoding the shikimate bypass route, such as dehydroshikimate dehydratase (QsuB), pyruvate kinase (Pyk1), and quinate/shikimate dehydrogenase (QsuD), were disrupted sequentially. An artificial operon containing several shikimate pathway genes, including aroE, aroB, aroF, and aroG were overexpressed to maximize the glucose uptake and intermediate flux. The rationally designed shikimate-overproducing C. glutamicum strain grown in an optimized medium produced approximately 37.3 g/l of shikimate in 7-L fed-batch fermentation. Overall, rational cell factory design and culture process optimization for the microbial-based production of shikimate will play a key role in complementing traditional plant-derived shikimate production processes.

Functional Characterization of aroA from Rhizobium leguminosarum with Significant Glyphosate Tolerance in Transgenic Arabidopsis

  • Han, Jing;Tian, Yong-Sheng;Xu, Jing;Wang, Li-Juan;Wang, Bo;Peng, Ri-He;Yao, Quan-Hong
    • Journal of Microbiology and Biotechnology
    • /
    • 제24권9호
    • /
    • pp.1162-1169
    • /
    • 2014
  • Glyphosate is the active component of the top-selling herbicide, the phytotoxicity of which is due to its inhibition of the shikimic acid pathway. 5-Enolpyruvylshikimate-3-phosphate synthase (EPSPS) is a key enzyme in the shikimic acid pathway. Glyphosate tolerance in plants can be achieved by the expression of a glyphosate-insensitive aroA gene (EPSPS). In this study, we used a PCR-based two-step DNA synthesis method to synthesize a new aroA gene ($aroA_{R.\;leguminosarum}$) from Rhizobium leguminosarum. In vitro glyphosate sensitivity assays showed that $aroA_{R.\;leguminosarum}$ is glyphosate tolerant. The new gene was then expressed in E. coli and key kinetic values of the purified enzyme were determined. Furthermore, we transformed the aroA gene into Arabidopsis thaliana by the floral dip method. Transgenic Arabidopsis with the $aroA_{R.\;leguminosarum}$ gene was obtained to prove its potential use in developing glyphosate-resistant crops.

ANALYSIS AND MANIPULATION OF CANDIDATE GENES FOR DIARRHEAL DISEASE VACCINE DEVELOPMENTS

  • Kim Young-Chang
    • 한국미생물학회:학술대회논문집
    • /
    • 한국미생물학회 2000년도 International Meeting 2000
    • /
    • pp.58-65
    • /
    • 2000
  • Diarrheal diseases are a major cause of both illness and death in developing countries and are caused by rotavirus, Shigella spp., Salmonella spp., enterotoxigenic Escherichia coli (ETEC), and Vibrio spp. In this study, for the development of vaccine against diarrheal diseases caused by Shigella sonei, Salmonella typhimurium, E. coli O157, and Vibrio cholerae, cloning and nucleotide sequence analysis of genes and characteristics of their gene products in E. coli were performed. For construction of attenuated strain of S. sonnei KNIH104 and Salmonella typhimurium KNIH100, the aroA genes were cloned, respectively. The recombinant plasmid $_pJP{\Delta}A45$ containing aroA deleted region and suicide vector $(_pJP5603)$ was constructed. The aroA gene deleted mutants were constructed using this recombinant plasmid. For cloning gene encoding antigenic region of E. coli O157 KNIH317, the O-antigen synthesis gene cluster and sit gene was cloned. The E. coli XL1-Blue cells harboring this recombinant plasmid showed cytotoxicity in Vero cells. The ctx gene was cloned for tile purpose of antigenic region against V. cholerae KNIH002. Sequence analysis confirmed that the virulence gene cassette was consisted of ace, zot, ctxA and ctxB genes.

  • PDF